Cosmosid, Inc.

Cosmosid, Inc., a for-profit genomic sequencing and bioinformatics services firm based in Rockville, Maryland, operates exclusively as a prime contractor providing DNA analysis, metagenomic sequencing, and taxonomic profiling to federal research and public-health agencies, with no subcontract footprint and no standing on government-wide contract vehicles.

The company's capability portfolio centers on next-generation sequencing, DNA extraction, bacterial isolate sequencing, shotgun sequencing, strain-level microbial identification, and bioinformatics analysis of complex environmental and clinical samples. Representative recent work includes a $123,100 firm-fixed-price purchase order from the Department of Veterans Affairs for DNA stool analysis services at the Long Beach VA (awarded February 2025); a $66,600 total small business set-aside purchase order from the USDA's Agricultural Research Service for 40M-read shotgun sequencing to support gut microbiome research at the Northeast Area Dairy and Functional Foods Research Unit (awarded August 2024); a $15,438.50 purchase order from the EPA's Office of Water for bacterial isolate sequencing and sequence data analysis (awarded July 2026); and a $100,000 firm-fixed-price purchase order from the USDA's Agricultural Research Service for next-generation sequencing of microbial samples (awarded July 2022). Cosmosid also holds a single-award Blanket Purchase Agreement with the U.S. Geological Survey (ceiling $80,000, running through March 2027) providing cloud-based bioinformatics analysis services including sequence data processing, taxonomic profiling, and antimicrobial resistance characterization.

Customer concentration is diffuse across federal research and mission support agencies. The top five agencies by award count (Interior's USGS, Agriculture's multiple ARS sub-components, and Veterans Affairs) account for 50% of recent awards, but the top five by potential value (Homeland Security's Office of Procurement Operations at $1.2 million, Army Medical Command at $1.1 million, and FDA at $755 thousand) signal a secondary tier of larger, defense-adjacent work that does not surface in award-count rankings. Across 16 distinct customer agencies served, Cosmosid holds a small footprint concentrated in environmental, agricultural, and clinical genomics research missions rather than IT or defense prime work.

Activity has declined year over year — four awards in 2022 to one in both 2024, 2025, and 2026 — with only one award (the USGS BPA's remaining $20 thousand) facing completion inside the next twenty-four months. The vendor competes in mixed set-aside and full-and-open landscapes; recent awards include total small business set-asides (USDA 2024 and 2022) and non-set-aside competitive purchases. Cosmosid has no presence on GSA Schedule, GWAC, or other government-wide IDV vehicles beyond the single-award USGS BPA, limiting positioning for cross-agency task-order scaling or teaming arrangements on larger, multiple-award vehicles.